drugset / Trial / NCT06370039
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during 4-week repeat dosing in subjects with moderate to severe dry eye disease.
Timeline
- Start
- 2024-03-27
- Primary completion
- 2024-07-03
- Completion
- 2024-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INV-102 | Unknown | 0.7 % | Topical |